Applying AI-Driven Biosimulation to Drug Discovery
Certara President Leif Pedersen explains how PBPK and QSP modeling, proven across 125+ FDA-approved drugs,…
Certara2026 年 6 月 2 日
Review: application and opportunities for machine learning and artificial intelligence in preclinical immunogenicity risk assessment
This review explores how artificial intelligence (AI), machine learning (ML), and quantitative systems pharmacology (QSP)…
Certara2026 年 6 月 2 日
ADC dose optimization: Applying model-informed strategies in development
Explore ADC dose optimization using model-informed strategies to balance efficacy and safety across antibody drug…
Certara2026 年 4 月 22 日
An Integrated Nonclinical and Clinical Risk Assessment of the Effects of Investigational ATRi Tuvusertib on QTc Interval in Patients With Solid Tumors
This publication highlights how pharmacometric modeling, supported by Certara, was used to inform dose selection…
Certara2026 年 3 月 25 日
Right Dose, Right Regimen: Model-Informed Strategies for Antibody–Drug Conjugates (ADCs)
Watch this on-demand webinar to learn how model-informed strategies using PopPK, PBPK, and QSP can…
Certara2026 年 3 月 25 日
Model-informed drug development to support nemolizumab clinical development in adults and adolescents with moderate to severe atopic dermatitis
This article describes how a model-informed drug development (MIDD) approach was used to support the…
Certara2026 年 3 月 24 日
ADC first-in-human (FIH) dose selection: Designing FIH studies for success
Optimize ADC First-in-Human Dose Selection with model-informed strategies and exposure–response insights to design safer, more…
Certara2026 年 3 月 3 日
Start right, finish strong: Antibody-drug conjugate (ADC) studies for success
Learn how to build regulatory-ready first-in-human (FIH) dose strategies for antibody-drug conjugates (ADCs). Discover how…
Certara2026 年 2 月 23 日
Population Pharmacokinetics of Clesrovimab in Preterm and Full-Term Infants
This study, published in Clinical Pharmacology & Therapeutics (CPT), shows how population pharmacokinetic modeling supports…
Certara2026 年 2 月 2 日
The rise of biologics discovery: From small molecules to sequences
Biologics in drug discovery is becoming more important by the year. See where biologics discovery…
Certara2026 年 1 月 15 日
